vs
CARTERS INC(CRI)与Surgery Partners, Inc.(SGRY)财务数据对比。点击上方公司名可切换其他公司
Surgery Partners, Inc.的季度营收约是CARTERS INC的1.2倍($885.0M vs $757.8M),CARTERS INC净利率更高(1.5% vs -1.7%,领先3.2%),Surgery Partners, Inc.同比增速更快(2.4% vs -0.1%),Surgery Partners, Inc.自由现金流更多($90.6M vs $-144.1M)
卡特公司是美国知名儿童服饰设计与销售龙头企业,由威廉·卡特于1865年创立,主打婴童服饰品类,凭借多年的行业深耕,在北美儿童服饰市场拥有较高的认可度与市场份额。
Surgery Partners, Inc.(NASDAQ代码:SGRY)旗下的United Surgical Partners International(USPI)是美国领先的日间手术护理服务商,总部位于得克萨斯州达拉斯,由唐·斯廷于1998年创立,专注于为患者提供便捷、高效的门诊外科医疗服务,运营多家合规手术中心,覆盖美国多地医疗需求场景。
CRI vs SGRY — 直观对比
营收规模更大
SGRY
是对方的1.2倍
$757.8M
营收增速更快
SGRY
高出2.5%
-0.1%
净利率更高
CRI
高出3.2%
-1.7%
自由现金流更多
SGRY
多$234.7M
$-144.1M
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $757.8M | $885.0M |
| 净利润 | $11.6M | $-15.0M |
| 毛利率 | 45.1% | — |
| 营业利润率 | 3.8% | 12.5% |
| 净利率 | 1.5% | -1.7% |
| 营收同比 | -0.1% | 2.4% |
| 净利润同比 | -80.1% | 86.2% |
| 每股收益(稀释后) | $0.32 | $-0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CRI
SGRY
| Q4 25 | — | $885.0M | ||
| Q3 25 | $757.8M | $821.5M | ||
| Q2 25 | $585.3M | $826.2M | ||
| Q1 25 | $629.8M | $776.0M | ||
| Q4 24 | — | $864.4M | ||
| Q3 24 | — | $770.4M | ||
| Q2 24 | — | $762.1M | ||
| Q1 24 | — | $717.4M |
净利润
CRI
SGRY
| Q4 25 | — | $-15.0M | ||
| Q3 25 | $11.6M | $-22.7M | ||
| Q2 25 | $446.0K | $-2.5M | ||
| Q1 25 | $15.5M | $-37.7M | ||
| Q4 24 | — | $-108.5M | ||
| Q3 24 | — | $-31.7M | ||
| Q2 24 | — | $-15.5M | ||
| Q1 24 | — | $-12.4M |
毛利率
CRI
SGRY
| Q4 25 | — | — | ||
| Q3 25 | 45.1% | — | ||
| Q2 25 | 48.1% | — | ||
| Q1 25 | 46.2% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率
CRI
SGRY
| Q4 25 | — | 12.5% | ||
| Q3 25 | 3.8% | 12.9% | ||
| Q2 25 | 0.7% | 13.5% | ||
| Q1 25 | 4.1% | 8.0% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | — | 7.9% | ||
| Q2 24 | — | 11.1% | ||
| Q1 24 | — | 10.6% |
净利率
CRI
SGRY
| Q4 25 | — | -1.7% | ||
| Q3 25 | 1.5% | -2.8% | ||
| Q2 25 | 0.1% | -0.3% | ||
| Q1 25 | 2.5% | -4.9% | ||
| Q4 24 | — | -12.6% | ||
| Q3 24 | — | -4.1% | ||
| Q2 24 | — | -2.0% | ||
| Q1 24 | — | -1.7% |
每股收益(稀释后)
CRI
SGRY
| Q4 25 | — | $-0.11 | ||
| Q3 25 | $0.32 | $-0.18 | ||
| Q2 25 | $0.01 | $-0.02 | ||
| Q1 25 | $0.43 | $-0.30 | ||
| Q4 24 | — | $-0.86 | ||
| Q3 24 | — | $-0.25 | ||
| Q2 24 | — | $-0.12 | ||
| Q1 24 | — | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $184.2M | $239.9M |
| 总债务越低越好 | — | $3.6B |
| 股东权益账面价值 | $864.6M | $1.7B |
| 总资产 | $2.5B | $8.1B |
| 负债/权益比越低杠杆越低 | — | 2.10× |
8季度趋势,按日历期对齐
现金及短期投资
CRI
SGRY
| Q4 25 | — | $239.9M | ||
| Q3 25 | $184.2M | $203.4M | ||
| Q2 25 | $338.2M | $250.1M | ||
| Q1 25 | $320.8M | $229.3M | ||
| Q4 24 | — | $269.5M | ||
| Q3 24 | — | $221.8M | ||
| Q2 24 | — | $213.5M | ||
| Q1 24 | — | $185.2M |
总债务
CRI
SGRY
| Q4 25 | — | $3.6B | ||
| Q3 25 | — | $3.5B | ||
| Q2 25 | — | $3.5B | ||
| Q1 25 | — | $3.4B | ||
| Q4 24 | — | $3.3B | ||
| Q3 24 | — | $3.1B | ||
| Q2 24 | — | $3.0B | ||
| Q1 24 | — | $2.8B |
股东权益
CRI
SGRY
| Q4 25 | — | $1.7B | ||
| Q3 25 | $864.6M | $1.7B | ||
| Q2 25 | $853.9M | $1.7B | ||
| Q1 25 | $847.2M | $1.7B | ||
| Q4 24 | — | $1.8B | ||
| Q3 24 | — | $1.9B | ||
| Q2 24 | — | $2.0B | ||
| Q1 24 | — | $2.0B |
总资产
CRI
SGRY
| Q4 25 | — | $8.1B | ||
| Q3 25 | $2.5B | $7.9B | ||
| Q2 25 | $2.5B | $8.0B | ||
| Q1 25 | $2.3B | $7.9B | ||
| Q4 24 | — | $7.9B | ||
| Q3 24 | — | $7.5B | ||
| Q2 24 | — | $7.5B | ||
| Q1 24 | — | $7.0B |
负债/权益比
CRI
SGRY
| Q4 25 | — | 2.10× | ||
| Q3 25 | — | 2.00× | ||
| Q2 25 | — | 1.98× | ||
| Q1 25 | — | 1.98× | ||
| Q4 24 | — | 1.83× | ||
| Q3 24 | — | 1.63× | ||
| Q2 24 | — | 1.56× | ||
| Q1 24 | — | 1.42× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-128.0M | $103.4M |
| 自由现金流经营现金流 - 资本支出 | $-144.1M | $90.6M |
| 自由现金流率自由现金流/营收 | -19.0% | 10.2% |
| 资本支出强度资本支出/营收 | 2.1% | 1.4% |
| 现金转化率经营现金流/净利润 | -11.04× | — |
| 过去12个月自由现金流最近4个季度 | — | $195.6M |
8季度趋势,按日历期对齐
经营现金流
CRI
SGRY
| Q4 25 | — | $103.4M | ||
| Q3 25 | $-128.0M | $83.6M | ||
| Q2 25 | $40.3M | $81.3M | ||
| Q1 25 | $-48.6M | $6.0M | ||
| Q4 24 | — | $111.4M | ||
| Q3 24 | — | $65.2M | ||
| Q2 24 | — | $82.8M | ||
| Q1 24 | — | $40.7M |
自由现金流
CRI
SGRY
| Q4 25 | — | $90.6M | ||
| Q3 25 | $-144.1M | $63.8M | ||
| Q2 25 | $24.1M | $57.9M | ||
| Q1 25 | $-59.0M | $-16.7M | ||
| Q4 24 | — | $89.1M | ||
| Q3 24 | — | $45.0M | ||
| Q2 24 | — | $55.9M | ||
| Q1 24 | — | $19.7M |
自由现金流率
CRI
SGRY
| Q4 25 | — | 10.2% | ||
| Q3 25 | -19.0% | 7.8% | ||
| Q2 25 | 4.1% | 7.0% | ||
| Q1 25 | -9.4% | -2.2% | ||
| Q4 24 | — | 10.3% | ||
| Q3 24 | — | 5.8% | ||
| Q2 24 | — | 7.3% | ||
| Q1 24 | — | 2.7% |
资本支出强度
CRI
SGRY
| Q4 25 | — | 1.4% | ||
| Q3 25 | 2.1% | 2.4% | ||
| Q2 25 | 2.8% | 2.8% | ||
| Q1 25 | 1.6% | 2.9% | ||
| Q4 24 | — | 2.6% | ||
| Q3 24 | — | 2.6% | ||
| Q2 24 | — | 3.5% | ||
| Q1 24 | — | 2.9% |
现金转化率
CRI
SGRY
| Q4 25 | — | — | ||
| Q3 25 | -11.04× | — | ||
| Q2 25 | 90.37× | — | ||
| Q1 25 | -3.13× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CRI
| Sales Channel Directly To Consumer | $362.3M | 48% |
| Sales Channel Through Intermediary | $283.8M | 37% |
| Other | $110.4M | 15% |
| Gift Cards | $1.3M | 0% |
SGRY
| Private Insurance | $460.5M | 52% |
| Government Revenue | $368.6M | 42% |
| Other | $19.8M | 2% |
| Self Pay Revenue | $19.6M | 2% |
| Other Patient Service Revenue Sources | $16.5M | 2% |